Notably, NOP56 silencing also inhibited NRAS-mutant lung cancer H1299 cells, although the effects on EGFR-mutant (EBC-1) or FGFR1-amplified (H520) lung cancer cells were negligible (Fig. S1A, B). This evidence concerns the gene FGFR1 and lung carcinoma.